Spyre Therapeutics Inc.
(SYRE)
undefined
undefined%
At close: undefined
24.12
0.12%
After-hours Dec 13, 2024, 04:15 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| PE Ratio | -0.11 | -0.11 | -1.19 | -1.30 | -0.78 | -0.88 | -0.75 | -0.49 |
| PS Ratio | 41.88 | 4.07 | 4.17 | 0.00 | 0.00 | 10.03 | 3.93 | 2.30 |
| PB Ratio | 0.20 | 0.19 | 0.93 | 0.75 | 1.02 | 0.58 | 0.41 | 0.17 |
| P/FCF Ratio | -0.37 | -0.12 | -1.44 | -1.31 | -0.91 | -1.20 | -0.81 | -0.56 |
| P/OCF Ratio | -0.37 | -0.12 | -1.45 | -1.39 | -0.93 | -1.21 | -0.83 | -0.57 |
| OCF/S Ratio | -28.19 | -8.60 | -0.72 | 0.00 | 0.00 | -2.07 | -1.18 | -1.02 |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quick Ratio | 2.67 | 1.06 | 1.23 | 2.28 | 1.01 | 1.87 | 2.44 | 4.19 |
| Current Ratio | 2.67 | 1.06 | 1.23 | 2.28 | 1.01 | 1.87 | 2.44 | 4.19 |
| Asset Turnover | 0.00 | 0.03 | 0.17 | 0.00 | 0.00 | 0.05 | 0.09 | 0.07 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Equity (ROE) | -184.11% | -166.61% | -78.39% | -57.85% | -130.25% | -65.77% | -54.11% | -34.46% |
| Return on Assets (ROA) | -99.10% | -117.81% | -59.86% | -50.05% | -94.07% | -57.05% | -48.57% | -32.35% |
| Return on Capital (ROIC) | -78.19% | -150.09% | -73.12% | -56.13% | -123.93% | -67.35% | -54.86% | -34.72% |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Profit Margin | -2.20% | 3.92% | 22.33% | 0.00% | 0.00% | 25.00% | 25.00% | 25.00% |
| Net Profit Margin | -9559.54% | -899.69% | -87.79% | 0.00% | 0.00% | -285.16% | -130.82% | -117.21% |